CYP21A2 and Hyponatremia: Patients (six males) with large deletions or conversions of CYP21A2 showed severe clinical manifestations including hyperpigmentation, vomiting, hypotension, hyponatremia, hyperkalemia, and shock, with a high level of 17-OHP (Table 4; Figure 4).